Evidence map›Paper›PMID 29448054›Full record

ArticleJournal of proteomics2018

RAGE-induced changes in the proteome of alveolar epithelial cells.

Charles A Downs, Nicholle M Johnson, George Tsaprailis, My N Helms

Abstract read
In one paragraph

Article in Journal of proteomics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. LIPS and PaOMediators of inflammation · 2024
    Observational
  5. Article
  6. Article
  7. Article
  8. Review
  9. The Balance between Two Branches of RAS Can Protect from Severe COVID-19 Course.Biochemistry (Moscow) Supplement. Series A, Membrane and cell biology · 2021
    Article
  10. Article
  11. RAGE in Cancer Lung: the End of a Long and Winding Road is in Sight.Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Charles A DownsBiobehavioral Health Science Division, College of Nursing & Division of Translational and Regenerative Medicine, College of Medicine, The University of Arizona, Tucson, AZ, United States. Electronic address: cdowns@email.arizona.edu.
Nicholle M JohnsonBiobehavioral Health Science Division, College of Nursing & Division of Translational and Regenerative Medicine, College of Medicine, The University of Arizona, Tucson, AZ, United States.
George TsaprailisArizona Research Laboratories, The University of Arizona, Tucson, AZ, United States.
My N HelmsDepartment of Internal Medicine, School of Medicine, University of Utah, Salt Lake City, UT, United States.
University of Arizona · USUniversity of Utah · US

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Teri L Bankhead · 1985 to 2026
$110.2M
NCI NIH HHS P30 CA023074
6 · The paper itself

Abstract

The receptor for advanced glycation end-products (RAGE) is a pattern recognition receptor and member of the immunoglobulin superfamily. RAGE is constitutively expressed in the distal lung where it co-localizes with the alveolar epithelium; RAGE expression is otherwise minimal or absent, except with disease. This suggests RAGE plays a role in lung physiology and pathology. We used proteomics to identify and characterize the effects of RAGE on rat alveolar epithelial (R3/1) cells. LC-MS/MS identified 177 differentially expressed proteins and the PANTHER Classification System further segregated proteins. Proteins involved in gene transcription (RNA and mRNA splicing, mRNA processing) and transport (protein, intracellular protein) were overrepresented; genes involved in a response to stimulus were underrepresented. Immune system processes and response to stimuli were downregulated with RAGE knockdown. Western blot confirmed RAGE-dependent changes in protein expression for NFκB and NLRP3 that was functionally supported by a reduction in IL-1β and phosphorylated p65. We also assessed RAGE's effect on redox regulation and report that RAGE knockdown attenuated oxidant production, decreased protein oxidation, and increased reduced thiol pools. Collectively the data suggest that RAGE is a critical regulator of epithelial cell response and has implications for our understanding of lung disease, specifically acute lung injury. SIGNIFICANCE STATEMENT: In the present study, we undertook the first proteomic evaluation of RAGE-dependent processes in alveolar epithelial cells. The alveolar epithelium is a primary target during acute lung injury, and our data support a role for RAGE in gene transcription, protein transport, and response to stimuli. More over our data suggest that RAGE is a critical driver of redox regulation in the alveolar epithelium. The conclusions of the present work assist to unravel the molecular events that underlie the function of RAGE in alveolar epithelial cells and have implications for our understanding of RAGE signaling during lung injury. Our study was the first proteomic comparison showing the effects of RAGE activation from alveolar epithelial cells that constitutively express RAGE and these results can affect a wide field of lung biology, pulmonary therapeutics, and proteomics.

Indexed as

Alveolar Epithelial CellsAnimalsCells, CulturedChromatography, LiquidNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinOxidation-ReductionProtein TransportProteomeRatsReceptor for Advanced Glycation End ProductsTandem Mass SpectrometryTranscription, GeneticNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, ratProteomeReceptor for Advanced Glycation End ProductsARDSLung injuryOxidative stressRedox regulation

Identifiers

PMID29448054
PMCPMC5978762
OpenAlexW2791797623

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.